Host cell proteins in biologics development: Identification, quantitation and risk assessment

Host cell proteins (HCPs) are those produced or encoded by the organisms and unrelated to the intended recombinant product. Some are necessary for growth, survival, and normal cellular processing whereas others may be non‐essential, simply carried along as baggage. Like the recombinant product, HCPs may also be modified by the host with a number of post‐translational modifications. Regardless of the utility, or lack thereof, HCPs are undesirable in the final drug substance. Though commonly present in small quantities (parts per million expressed as nanograms per milligrams of the intended recombinant protein) much effort and cost is expended by industry to remove them. The purpose of this review is to summarize what is of relevance in regards to the biology, the impact of genomics and proteomics on HCP evaluation, the regulatory expectations, analytical approaches, and various methodologies to remove HCPs with bioprocessing. Historical data, bioinformatics approaches and industrial case study examples are provided. Finally, a proposal for a risk assessment tool is provided which brings these facets together and proposes a means for manufacturers to classify and organize a control strategy leading to meaningful product specifications. Biotechnol. Bioeng. 2009;103: 446–458. © 2009 Wiley Periodicals, Inc.

[1]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[2]  Victor A. McKusick,et al.  A new discipline, a new name, a new journal , 1987 .

[3]  J. Bailey,et al.  Characterization of inclusion bodies in recombinant Escherichia coli producing high levels of porcine somatotropin. , 1993, Journal of biotechnology.

[4]  K. Veeraragavan.  Studies on two major contaminating proteins of the cytoplasmic inclusion bodies in Escherichia coli. , 1989, FEMS microbiology letters.

[5]  L C Eaton,et al.  Host cell contaminant protein assay development for recombinant biopharmaceuticals. , 1995, Journal of chromatography. A.

[6]  P. Panfili,et al.  Quantitation of DNA and protein impurities in biopharmaceuticals. , 1991, Analytical chemistry.

[7]  A. Hunter,et al.  Use of cyclohexanedimethanol as a nonflammable organic solvent for industrial scale reversed phase chromatography. , 2008, Journal of chromatography. A.

[8]  Jon Coffman,et al.  High‐throughput screening of chromatographic separations: IV. Ion‐exchange , 2008, Biotechnology and bioengineering.

[9]  G. Anderson,et al.  Dynamic range expansion applied to mass spectrometry based on data-dependent selective ion ejection in capillary liquid chromatography fourier transform ion cyclotron resonance for enhanced proteome characterization. , 2001, Analytical chemistry.

[10]  A. Saul,et al.  A quantitative slot blot assay for host cell protein impurities in recombinant proteins expressed in E. coli. , 2005, Journal of immunological methods.

[11]  K. Champion,et al.  Proteomic studies support the use of multi‐product immunoassays to monitor host cell protein impurities , 2006, Proteomics.

[12]  G. Belfort,et al.  Optimized Removal of Soluble Host Cell Proteins for the Recovery of met‐Human Growth Hormone Inclusion Bodies from Escherichia coli Cell Lysate Using Crossflow Microfiltration , 2008, Biotechnology progress.

[13]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[14]  J. Thalhamer,et al.  Cascade immunization: a method of obtaining polyspecific antisera against crude fractions of antigens. , 1984, Journal of immunological methods.

[15]  J. Nishihara,et al.  Similarity of the Escherichia coli proteome upon completion of different biopharmaceutical fermentation processes , 2001, Proteomics.

[16]  J. Bailey,et al.  Protein composition of Vitreoscilla hemoglobin inclusion bodies produced in Escherichia coli. , 1990, The Journal of biological chemistry.

[17]  R. van Reis,et al.  Application of high‐performance tangential flow filtration (HPTFF) to the purification of a human pharmaceutical antibody fragment expressed in Escherichia coli , 2008, Biotechnology and bioengineering.

[18]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[19]  A. Hunter,et al.  Separation of product associating E. coli host cell proteins OppA and DppA from recombinant apolipoprotein A‐IMilano in an industrial HIC unit operation , 2009, Biotechnology progress (Print).

[20]  C. Dowd,et al.  Performance of a membrane adsorber for trace impurity removal in biotechnology manufacturing. , 2005, Journal of chromatography. A.

[21]  A. Rathore,et al.  Analysis for residual host cell proteins and DNA in process streams of a recombinant protein product expressed in Escherichia coli cells. , 2003, Journal of pharmaceutical and biomedical analysis.

[22]  J Godovac-Zimmermann,et al.  Perspectives for mass spectrometry and functional proteomics. , 2001, Mass spectrometry reviews.

[23]  D. James,et al.  Comparative proteomic analysis of GS-NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate. , 2004, Biotechnology and bioengineering.

[24]  N. W. Davis,et al.  The complete genome sequence of Escherichia coli K-12. , 1997, Science.

[25]  T. Ohmura,et al.  Properties of recombinant hepatitis B vaccine. , 1987, Biochemical and biophysical research communications.

[26]  Michael Rubacha,et al.  Demonstration of Robust Host Cell Protein Clearance in Biopharmaceutical Downstream Processes , 2008, Biotechnology progress.

[27]  Leroy Hood,et al.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.

[28]  M. Wadhwa,et al.  Incidence of GM-CSF antibodies in cancer patients receiving GM-CSF for immunostimulation. , 2001, Clinical immunology.

[29]  Lisa M. D'Souza,et al.  Genome sequence of the Brown Norway rat yields insights into mammalian evolution , 2004, Nature.

[30]  Andrew J. S. Jones,et al.  Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone. , 1986, Journal of immunological methods.

[31]  D. de Groote,et al.  Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. , 1992, Cytokine.

[32]  Kelvin H. Lee,et al.  A two‐dimensional electrophoresis map of Chinese hamster ovary cell proteins based on fluorescence staining , 2004, Electrophoresis.

[33]  Deborah K Follman,et al.  Factorial screening of antibody purification processes using three chromatography steps without protein A. , 2004, Journal of chromatography. A.

[34]  A. Meager.  Measurement of cytokines by bioassays: theory and application. , 2006, Methods.

[35]  André Goffeau,et al.  The yeast genome directory. , 1997, Nature.

[36]  Brian Hubbard,et al.  Downstream processing of monoclonal antibodies--application of platform approaches. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[37]  R. House.  Cytokine measurement techniques for assessing hypersensitivity. , 2001, Toxicology.

[38]  John R. Crowther,et al.  The ELISA Guidebook , 2000, Methods in Molecular Biology™.

[39]  P. Hinckley,et al.  Host cell protein clearance during protein a chromatography: Development of an improved column wash step , 2008, Biotechnology progress.

[40]  James E. Bailey,et al.  Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli , 1992, Applied Microbiology and Biotechnology.

[41]  D. Hochstrasser,et al.  From Proteins to Proteomes: Large Scale Protein Identification by Two-Dimensional Electrophoresis and Arnino Acid Analysis , 1996, Bio/Technology.

[42]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[43]  T. Nguyen,et al.  Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virus. , 2001, Journal of immunological methods.

[44]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[45]  Erdahl T. Teber,et al.  Identification of cellular changes associated with increased production of human growth hormone in a recombinant Chinese hamster ovary cell line , 2003, Proteomics.